Minute Insight: Abbott’s Libre 3 Finds Route To NHS Patients With YpsoMed And CamDiab Partnership

Abbott’s flagship CGM, the FreeStyle Libre 3, will soon become available in the UK through the National Health Service as part of a hybrid closed-loop system utilizing Ypsomed and CamDiab’s technologies.  

Minute Insight
• Source: Informa/Alamy

More from Diabetic Care

More from Device Area